Oct 5 (Reuters) - AstraZeneca said on Monday it had opened a new research and development center in Cambridge, Massachusetts, as part of a more than $1 billion investment in the state to expand its research operations and workforce. (...
The current investment concerns a new research and development center in Cambridge, a move that is expected to increase its human resources in that state by more than 50% in the coming years.